Abstract
Microorganisms produce low-molar-mass secondary metabolites exhibiting different biological activities, which are used.e.g., in medicine as antimicrobial and antifungal agents, alkaloids and toxins. Some of these substances have highly diverse biological activities and unusual structures. They are produced by streptomycetes, fungi, and bacilli, but interesting products have also been obtained from microorganisms growing in extreme conditions. Several thousands of microbial products have so far been discovered and many other, which can be potentially useful, and/or prospective for human use, can still be in the offing.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Adam, S., Then R.L., Angehrn P.: (E)-Acetylmethylenepenicillin, a potent β-lactamase inhibitor.J. Antibiot. 40, 108–109 (1987).
Akiyama T., Harada, S., Koima F., Takahashi Y., Imada C., Okami Y., Muraoka Y., Aoyagi T., Takeuchi T.: Fluostatins A and B, new inhibitors of dipeptidyl peptidase III, produced byStreptomyces sp. TA-3391. I. Taxonomy of producing strain, production, isolation, physico-chemical properties and biological properties.J. Antibiot. 51, 553–559 (1998a).
Akiyama T., Nakamura K., Takahashi Y., Naganawa H., Muraoka Y., Aoyagi T., Takeuchi T.: Fluostatins A and B, new inhibitors of dipeptidyl peptidase III, produced byStreptomyces sp. TA-3391. II. Structure determination.J. Antibiot. 51, 586–588 (1998b).
Akiyama T., Harada S., Koima F., Kinoshita N., Hamada M., Muraoka Y., Aoyagi T., Takeuchi T.: Epostatin, new inhibitor of dipeptidyl peptidase II, produced byStreptomyces sp. MJ995-OF5. I. Taxonomy of producing strain, fermentation, isolation, physico-chemical properties and biological properties.J. Antibiot. 51, 253–260 (1998c).
Alberts A. W., Chen J., Kuron G., Hunt V., Hoffman C.: Mevinolin, a highly potent competitive HMG-CoA reductase and a cholesterol lowering agent.Proc. Natl. Acad. Sci. USA 77, 3957–3961 (1980).
Aldridge K.E.: A new potent β-lactamase inhibitor, BRL 42715, with inherent activity againstBacteroides fragilis group strains.Clin. Infect. Dis. 16, 335–338 (1993).
An G.H., Bielich J., Auerbach R., Johnson E.A.: Isolation and characterization of carotenoid hyperproducing mutants of yeast by flow cytometry and cell sorting.Biotechnology 9, 70–73 (1991).
Bèhal V: Bioactive products fromStreptomyces.Adv. Appl. Microbiol. 47, 113–156 (2000).
Borgstrom B.: Mode of action of tetrahydrolipstatin: a derivative of the naturally occurring lipase inhibitor lipstatin.Biochim. Biophys. Acta 962, 308–316, (1888).
Box S.J., Shelley P.R., Tyler J.W., Verrall M.S., Warr S.R.C., Bodger A.M., Levy M.A., Banks R.M.: 27-O-Demethylrapamycin, an immunosuppressant compound produced by a new strain ofStreptomyces hygroscopicus.J. Antibiol. 48, 1347–1349 (1995).
Burkhard C.N.: Ivermectin: an assesstment of its pharmacology, microbiology and safety.Vet. Hum. Toxicol. 42, 30–35 (2000).
Dreyfuss M., Harri E., Hofmann H., Kobel H., Pach W.: Cyclosporin A and C, new metabolites fromTrichoderma polyspora.Eur. J. Appl. Microbiol. 3, 125–133 (1976).
Ehrlich J., Coffey G.L., Fisher M.W., Hillegas A.B., Kohreger D.L., Machamer H.E., Rightsel W.A., Roegner F.R.: 6-Diazo-5-oxo-t-norleucine, a new tumor inhibitory substance.Antibiol. Chemother. 6, 487–496 (1956).
Fang T.J., Cheng Y.S.: Isolation of astaxanthin over-producing mutants ofPhaffia rhodozyma and their fermentation kinetics.Chung Hua Min Kuo Wei Sheng Wu Chi Mien 1 Hsueh Tsa Chin 25, 209–222 (1992).
Hadvary P., Sidler W., Meister W., Vetter, W., Wolfer H.: The lipase inhibitor tetrahydrolipstatin binds covalently to the putative active site serine of pancreatic lipase.J. Biol. Chem. 266, 2020–2027 (1991).
Hutchinson C.R.: Anthracyclines pp. 331–357 inGenetics and Biochemistry of Antibiotic Production (L.C. Vining, C. Stuttard, Eds.). Buterworth-Heinemann, Newton (USA) 1995.
Ikeda H., Omura S.: Control of avermectin biosynthesis inStreptomyces avermitilis for the selective production of used component.J. Antibiot. 48, 549–562 (1995).
Johnson E.A., Lewis M.J.: Astaxanthin formation by the yeastPhaffia rhodozyma.J. Gen. Microbiol. 115, 173–183 (1979).
Kang S.G., Park H.U., Lee H.S., Kim H.T., Lee K.J.: New β-lactamase inhibitory protein (BLIP-I) fromStreptomyces exfoliatus SMF 19 and its roles on the morphological differentiation.J. Biol. Chem. 275, 16851–16856 (2000).
Kawada S.-Z., Yamashita Y., Ochiai K., Iwasaki T., Tokiguchi T., Nakano H.: Terpentecin and UCT4B, new family of topoisomerase II targeting, antitumor antibiotic produced byStreptomyces: producing organism, fermentation and large scale purification.J. Antibiot. 48, 211–216 (1995).
Kennedy D.G., Hughes P.J., Blanchflower, W.J.: Ionofore residues in eggs in Northern Ireland: incidence and cause.Food Addit. Contam. 15, 535–541 (1998).
Kim H.-S., Hong Y.-S., Kim Y.-H., Uoo, O.-J., Lee J.-J. New anthracycline metabolites produced by the aklavinone 11-hydroxylase gene inStreptomyces galilaeus ATCC31133.J. Antibiot 49, 355–360 (1996).
Lampis G., Deidda D., Maullu C., Madeddou M.A., Pompei R. Monache F.D., Satta G.: Sattabacins and sattazolins: new biological active compounds with antiviral properties extracted, from aBacillus sp.J. Antibiot. 48, 967–972 (1995).
Ma L., Marquardt D., Takemoto L., Center M.S.: Analysis ofP-glycoprotein phosphorylation in HL60 cells isolated for resistance to vincristine.J. Biol. Chem. 266, 5593–5599 (1991).
MacNeil D.J.: Avermectins, pp. 421–442 inGenetics and Biochemistry of Antibiotic Production (L.C. Vining, C. Stuttart, Eds.), Buterworth-Heinemann, Newton (USA) 1995.
McCord J.M., Fridovich I.: Superoxide dismutase assay: an enzyme function for erythrocuprein (hemocuprein).J. Biol. Chem. 244, 6049–6050 (1969).
McGuire J.N., Wilson S.R., Rinehart K.L.: Cremeomycin, a novel cytotoxic antibiotic fromStreptomyces cremeus. Structure elucidation and biological activityJ. Antibiot. 48, 516–519 (1995).
Meingassner J.G., Stutz A.: Immunosuppressive macrolides of the type FK 506: a novel class of topical agents for treatment of skin disease.J. Invest. Dermatol. 98, 851–855 (1992).
Morishita T., Sato A., Ando T., Oizumi K., Miyamoto M., Enokita R., Okazaki T.: A novel bone resorption inhibitor A-75943 isolated fromStreptomyces sp. SANK 61296.J. Antibiot. 51, 531–538 (1998).
Nashihara Y., Tsuji E., Yamagishi, Y., Sakamoto K., Tsurumi Y., Furukawa S., Ohtsu R., Kino T., Hino M., Yamashita M., Hashimoto S.: FR198248, a new anti-influenza agent isolated fromAspergillus terreus no. 12830. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activities.J. Antibiot. 54, 136–143 (2001a).
Nashihara Y., Takase S., Tsuhi E., Hatanaka H., Hashimoto S.: New anti-influenza agents, FR198248 and its derivatives. II. Characterization of FE198248, its related compounds and some derivatives.J. Antibiot. 53, 287–303 (2001b).
Ogawa, H., Yamashida Y., Katahira R., Chiba S., Iwasaki T., Ashizawa T., Nakano H.: UCH9, a new antitumor antibiotic produced byStreptomyces: I. Producing organism, fermentation isolation and biological activities.J. Antibiot. 51, 261–266 (1998).
Omura S., Ohno H., Saheki T., Yoshida M., Nakagawa A.: Elasnin, a new human granulocyte elastase inhibitor produced by strain ofStreptomyces.Biochem. Biophys. Res. Commun. 83, 704–709 (1978).
Omura S., Sasaki Y., Iwai Y., Takeshima H.: Staurosporin, a potencionally important gift from a microorganism.J. Antibiot. 48, 535–545 (1995).
Oohata N., Hori Y., Yamagishi, Y., Fuita T., Takase S., Yamashita M., Terano H., Okuhara M.: A new aromatase inhibitor. FR901537. I. Taxonomy, fermentation, isolation, physico-chemical characteristics and biological activities.J. Antibiot. 48, 757–762 (1995).
Otsuka, T., Muramatsu Y., Higaki T., Nakanishi T., Takase S., Hatanaka H., Okamaoto M., Hino M., Hashimoto S.: WF14861, a new cathepsins B and L inhibitor produced byColletotrichum sp I. Taxonomy, production, purification and structure elucidation.J. Antibiot. 52, 536–541 (1999).
Ottesen E.A., Campbell W.C.: Ivermectin in human, medicine.J. Antimicrob. Chemother. 34, 195–203 (1994).
Pacandl M.: Efficacy of salinomycin, monensin and lasalocid against spontaneouslyEimeria infection in rabbits.Folia Parasitol. 33, 195–198 (1986).
Reading C., Cole M.: Clavulanic acid.Antimicrob. Agents. Chemother.11, 852–857 (1977).
Rho M.-C., Zoyashima M., Hayashi M., Uchida R., Siomi K., Komyiama K., Omura S.: Enhance of of drug accumulation by andastin A produced byPenicillium sp. FO-3929 in vincristine-resistant KB cells.J. Antibiot. 50, 68–72 (1998).
Rho M.-C., Hayashi M., Fukami A., Obata R., Sunazuka T., Tomoda H., Komyiama K., Omura S.: Reversal of multidrug resistance by 7-O-benzoylpyripyropene A in multidrug-resistant tumor cells.J. Antibiot. 53, 1201–1206 (2000).
Sato N., Yusa K., Naito M., Tsuruo T. Staurosporine, a potent inhibitor of C-kinase enhances drug accumulation in multidrugresistant cells.Biochem. Biophys. Res. Commun. 173, 1252–1257 (1990).
Sawada S., Suzuki G., Kawase Y., Takaku F.: Novel immunosuppresive agent, FK 506.In vitro effect on the cloned T cell activation.J. Immunol. 139, 1797–1803 (1987).
Scheen A.J., Ernest P., Letiexhe M.R.: Pharmacy-clinics medication of the month. Orlistate (Xenical).Rev. Med. Liège 54, 192–196 (1999).
Schroeder W.A., Johnson E.A.: Singlet oxygen and peroxyl radicals regulate carotenoid biosynthesis inPhaffia rhodozyma.J. Biol. Chem. 270, 18374–18379 (1995).
Sehgal S.N., Molnar-Kimber K., Ocain T.D., Weichman B.M.: Rapamycin: a novel immunosuppressive macrolide.Med. Res. Rev. 14, 1–22 (1994).
Sigler K., Chaloupka J., Brozmanová J., Stadler N., Höfer M.: Oxidative stress in microorganisms—I. Microbial.vs. higher cells—damage and defenses in relation to cell aging and death.Folia Microbiol. 44, 587–624 (1999).
Šturdiková M., Proksa B., Fuska J., Stančíková M.: Vermilutin, an elastase inhibitor produced byPenicillium vermiculatum.Biologia 50, 233–236 (1995).
Suzuki K., Nagao K., Monnai Y., Yagi A., Uyeda M.: Topostatin, a novel inhibitor of topoisomerase I and II produced,Thermomonospora alba strain no. 1520.J. Antibiot. 51, 991–998 (1998).
Tabata N., Tomoda H., Takahashi Y., Haneda K., Iwai Z., Woodruff H.B., Omura S.: Diomycins, new anticoccidial agens produced byStreptomyces sp. I. Production, isolation and physico-chemical and biological properties.J. Antibiot. 46, 756–761 (1993).
Thompson A.B.R., De Pover A., Keelan M., Jarocka-Cyrta E., Clandinin M.T.: Inhibition of lipid absorption as an approach to the treatment of obesity.Meth. Enzymol. 286, 3–44 (1997).
Thompson C.J., Seto H.: Bialaphos, pp. 197–222. inBiogenetics and Biochemistry of Antibiotic Production (L.C. Vining, C. Stuttard, Eds). Buterworth-Heinemann, Newton (USA) 1995.
Tomoda H., Tabata N., Masuma R., Si S.-Y., Omura S.: Erabulenols inhibitors of cholestryl ester transfer protein produced byPenicillium sp. FO-5637.J. Antibiot. 51, 618–623 (1998).
Umezawa H., Aoyagi T., Okura A., Morishima H., Takeuchi T., Okami Y.: Elastinal, a new elastase inhibitor produced by actinomycetes.J. Antibiot. 326, 787–789 (1973).
Umezava K., Aoyagi T., Suda D., Hamada M., Takeuchi T.: Bestatin, an inhibitor of amidopeptidase B, produced by actinomycetes.J. Antibiot. 30, 170–173 (1976).
Yueda M., Yokomizo K., Miyamoto Y., Habid E.-S.E.: Fattiviracin A1, a novel antiherpetic agent produced byStreptomyce microflavus strain no. 2445. I. Taxonomy, fermentation, isolation, physico-chemical properties and structure elucidation.J. Antibiot. 41, 823–828 (1998).
Westley I.: Polyether antibiotics: versatile carboxylic ionophores byStreptomyces.Adv. Appl. Microbiol. 22, 177–223 (1977).
Woo J.-T., Ono H., Tsui T.: Cathestatins, new cysteine protease inhibitors produced byPenicillium citrinium.Biosci Biotech. Biochem. 59, 350–352 (1995).
Yamada T., Hiratake J., Aikawa M., Suizu T., Saito Y., Kawato A., Suginami K., Oda J.: Cysteine protease inhibitors produced by the industrial koji mold,Aspergillus oryzae O-1018.Biosci. Biotech. Biochem. 62, 907–914 (1998).
Yoshimura, S., Otsuka T., Tsurumi Y., Muramatsu Y., Hatanaka H., Okamoto M., Hasmimoto S., Okuhara M.: WA8242 A1, A2 and B, novel secretory phospholiase A2 inhibitors produced byStreptomyces violaceus-niger., J. Antibiot. 51, 1–7 (1998).
Zhou X.Y., Kitzis M.D., Acar J.F., Gutmann L.: Activity of the β-lactamase inhibitor BRL 42715 against cephalosporins produced byEnterobacteriaceae.J. Antimicrob. Chemother. 31, 473–480 (1993).
Žiżka Z.: Biological effects of macrotetrolide, antibiotics and nonactic acids.Folia Microbiol. 43, 7–14 (1998).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Běhal, V. Nontraditional microbial bioactive metabolites. Folia Microbiol 46, 363–370 (2001). https://doi.org/10.1007/BF02814422
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02814422